The effects of anxiety on relapse of patients with opioid use disorders under methadone maintenance treatment: control of the confounding variables

References

• Afsar, A., Bashirian, S., Poorolaja, J., Hazavehei, S., Vatan Nawaz, E., & Zinat Motlagh, F. (2014). Predictive factors of relapse among patients treated with methadone maintenance treatment referred to addiction centers in Hamadan based on health belief model. Health System Research, 9(4), 2034–2045.
   Google Scholar
• Ahmadi, J., Toobaee, S., Kharras, M., & Radmehr, M. (2003). Psychiatric disorders in opioid dependants. The International Journal of Social Psychiatry, 49(3), 185–191. doi:10.1177/00207640030493004
   PubMed Web of Science ®Google Scholar
• Anderson, J. F., & Warren, L. D. (2004). Client retention in the British Columbia Methadone Program, 1996–1999. Canadian Journal of Public Health, 95(2), 104–109.
   PubMed Web of Science ®Google Scholar
• Beck, A. T., Epstein, N., Brown, G., & Steer, R. A. (1988). An inventory for measuring clinical anxiety: psychometric properties. Journal of Consulting and Clinical Psychology, 56(6), 893–897. doi:10.1037/0022-006x.56.6.893
   PubMed Web of Science ®Google Scholar
• Fard, J. H., Gorji, M. A., Jannati, Y., Golikhatir, I., Bozorgi, F., Mohammadpour, R., & Gorji, A. M. (2014). Substance dependence and mental health in northern Iran. Annals of African Medicine, 13(3), 114–118. doi:10.4103/1596-3519.134389
   PubMedGoogle Scholar
• Fernandez, M. J., Gonzalez Garcia, P. M., Saiz Martinez, P., Gutierrez, C. E., & Bobes, G. J. (2001). Influence of psychiatric disorders in the effectiveness of a long-term methadone maintenance treatment. Actas Espanolas De Psiquiatria, 29(4), 228–232.
   PubMed Web of Science ®Google Scholar
• Glantz, M. D., Anthony, J. C., Berglund, P. A., Degenhardt, L., Dierker, L., Kalaydjian, A., … Kessler, R. C. (2009). Mental disorders as risk factors for later substance dependence: estimates of optimal prevention and treatment benefits. Psychological Medicine, 39(8), 1365–1377. doi:10.1017/s0033291708004510
   PubMed Web of Science ®Google Scholar
• Gottheil, E., Sterling, R. C., & Weinstein, S. P. (1993). Diminished illicit drug use as a consequence of long-term methadone maintenance. Journal of Addictive Diseases, 12(4), 45–57. doi:10.1300/J069v12n04_04
   PubMedGoogle Scholar
• Hosseini, F., Yassini, M., Ahmadieh, M., Vafaei_Nasab, M., Kholasezadeh, G., & Dastjerdi, G. (2010). Retention rate in methadone maintenance therapy. The Journal of Shahid Sadoughi University of Medical Sciences, 18(3), 152–158.
   Google Scholar
• Jiang, H., Han, Y., Du, J., Wu, F., Zhang, R., Zhang, H., & Zhao, M. (2014). Factors associated with one year retention to methadone maintenance treatment program among patients with heroin dependence in China. Substance Abuse Treatment, Prevention, and Policy, 9, 11. doi:10.1186/1747-597x-9-11
   PubMed Web of Science ®Google Scholar
• Kaviani, H., & Mousavi, A. S. (2008). Psychometric properties of the Persian version of beck anxiety inventory (BAI). Tehran University Medical Journal, 66(2): 136–140.
   Google Scholar
• Lejuez, C. W., Zvolensky, M. J., Daughters, S. B., Bornovalova, M. A., Paulson, A., Tull, M. T., … Otto, M. W. (2008). Anxiety sensitivity: a unique predictor of dropout among inner-city heroin and crack/cocaine users in residential substance use treatment. Behaviour Research and Therapy, 46(7), 811–818. doi:10.1016/j.brat.2008.03.010
   PubMed Web of Science ®Google Scholar
• Marsch, L. A. (1998). The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: a meta-analysis. Addiction, 93(4), 515–532.
   PubMed Web of Science ®Google Scholar
• Moeini, M., Razzaghi, O. M., Mahmoodi, M., & Pashaeie, T. (2014). Analysis of retention time among a sample of opioid dependents participating in the methadone maintenance treatment program in Iran. Journal of School of Public Health and Institute of Public Health Research, 11(3), 55–64.
   Google Scholar
• Parvaresh, N., Masoudi, A., Majidi-Tabrizi, S., & Mazhari, S. (2012). The correlation between methadone dosage and comorbid psychiatric disorders in patients on methadone maintenance treatment. Addiction and Health, 4(1–2), 1–8.
   PubMedGoogle Scholar
• Riahi, A., Khanjani, N., & Ahmadipoor, H. (2015). Factors R-elated to treatment failure in patients under methadone treatment at drug rehabilitation centers. Health-Based Research, 1(2), 115–122.
   Google Scholar
• Sadock, B. J., Sadock, V. A., & Ruiz, P. (2015). Kaplan & Sadock’s synopsis of psychiatry: Behavioral sciences/clinical psychiatry. Philadelphia, USA: Lippincott Williams & Wilkins.
   Google Scholar
• Sheerin, I., Green, T., Sellman, D., Adamson, S., & Deering, D. (2004). Reduction in crime by drug users on a methadone maintenance therapy programme in New Zealand. The New Zealand Medical Journal, 117(1190), U795.
   PubMedGoogle Scholar
• Shirani, S., Shakiba, M., Soleymanzadeh, M., & Esfandbod, M. (2010). Can opium abuse be a risk factor for carotid stenosis in patients who are candidates for coronary artery bypass grafting? Cardiology Journal, 17(3), 254–258.
   PubMed Web of Science ®Google Scholar
• Solimani, R., Najafi, K., Allahi, M., & Sharghi, A. (2013). Anxiety and depression in the patients undergoing methadone maintenance therapy. Journal of Guilan University of Medical Sciences, 22(87), 64–69.
   Google Scholar
• United Nations Office on Drugs and Crime(UNODC). (2017). World drug report. Vienna, Austria.
   Google Scholar
• Yang, F., Lin, P., Li, Y., He, Q., Long, Q., Fu, X., & Luo, Y. (2013). Predictors of retention in community-based methadone maintenance treatment program in Pearl River Delta, China. Harm Reduction Journal, 10, 3. doi:10.1186/1477-7517-10-3
   PubMed Web of Science ®Google Scholar